Q1 2025 saw 27% revenue growth and improved margins, with strong South American and BRF performance offsetting North American margin pressure. The proposed Marfrig-BRF merger aims for BRL 805 million in annual synergies and significant tax benefits, creating a global multi-protein leader.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.